TAKEDA PHARMACEUTICAL CO LTD TAK (last ticker on record)
CIK 1395064Its SEC filings (opens in a new tab)
- SEC/DOJ scrutiny
These figures describe clients, not conduct. A lawyer or firm can serve many companies that later had trouble for reasons that have nothing to do with their work, and nothing here says any lawyer or firm did anything wrong.
- Red flags
- 1
- Newest began May 2020
- Largest fall in its shares
- —
- None of 95% on record
- Law firms
- 3
- Linked to 5 or more companies
- Lawyers
- 0
- Linked to 5 or more companies
What happened
- A filing mentions cooperating with the Justice DepartmentForm 6-K (opens in a new tab)
An SEC release can name a company’s officer, or its stock as what a scheme sold or moved, so the company may be the victim. Each link goes to what to read.
Law firms
The ratios are about all the companies linked to each one, this one included: how many had that outcome, as a multiple of what comparable companies show. 1.00 means no more than expected.
- Nishimura & AsahiFirst linked Aug 2019 · Named in a filing · 6 linked companiesSEC/DOJ scrutiny 1.45× · Went dark 0.00× · 95% wipeout 0.00×
- Sullivan & CromwellFirst linked Sep 2018 · Named in SEC correspondence · 1,047 linked companiesSEC/DOJ scrutiny 1.40× · Went dark 0.15× · 95% wipeout 0.69×
- Linklaters LLPFirst linked Sep 2018 · Text search only · 156 linked companiesSEC/DOJ scrutiny 1.05× · Went dark 0.00× · 95% wipeout 0.63×
| Name | First linked | How it is known | Linked companies | SEC/DOJ scrutiny | Went dark | 95% wipeout |
|---|---|---|---|---|---|---|
| Nishimura & Asahi | Aug 2019 | Named in a filing | 6 | 1.45 | 0.00 | 0.00 |
| Sullivan & Cromwell | Sep 2018 | Named in SEC correspondence | 1,047 | 1.40 | 0.15 | 0.69 |
| Linklaters LLP | Sep 2018 | Text search only | 156 | 1.05 | 0.00 | 0.63 |